Thyroid remnant ablation in differentiated thyroid cancer-Reference-Cited by-同舟云学术

Thyroid remnant ablation in differentiated thyroid cancer

Published:2015-11 Issue:11 Volume:36 Page:1100-1106
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Campennì Alfredo,Giovanella Luca,Pignata Salvatore A.,Violi Maria A.,Siracusa Massimiliano,Alibrandi Angela,Moleti Mariacarla,Amato Ernesto,Ruggeri Rosaria M.,Vermiglio Francesco,Baldari Sergio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference30 articles.

1. Adjuvant thyroid remnant ablation in patients with differentiated thyroid carcinoma confined to the thyroid: a comparison of ablation success with different activities of radioiodine (I-131).;Prpic;Ann Nucl Med,2012

2. New insights in risk stratification of differentiated thyroid cancer.;Papaleontiou;Curr Opin Oncol,2014

3. Cancer statistics, 2013.;Siegel;CA Cancer J Clin,2013

4. . The role of surgery in the current management of differentiated thyroid cancer.;Conzo;Endocrine,2014

5. Moving toward a better understanding of radioiodine action.;Ho;Endocrine,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Theranostics of Thyroid Cancer;Seminars in Nuclear Medicine;2024-07

2. Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative 131I Administration: A Real Life Study;Cancers;2023-04-22

3. Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients;Cancers;2023-04-11

4. False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer;Endocrine;2023-03-16

5. Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers;Cancers;2022-11-16